Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience.
Atoosa RabieeBrett SadowskiNia AdenijiPonni V PerumalswamiVeronica NguyenAkshata MogheNyan L LattSonal KumarCostica AlomanAndreea M CatanaPatricia Pringle BloomKenneth D ChavinRotonya M CarrWinston DunnVincent L ChenElizabeth S AbyJose D DebesRenumathy Dhanasekarannull nullPublished in: Hepatology (Baltimore, Md.) (2020)
Liver injury is associated with higher mortality and ICU admission in LT recipients with COVID-19. Hence, monitoring liver enzymes closely can help in early identification of patients at risk for adverse outcomes. Reduction of immunosuppression during COVID-19 did not increase risk for mortality or graft failure.
Keyphrases
- liver injury
- coronavirus disease
- drug induced
- sars cov
- end stage renal disease
- cardiovascular events
- respiratory syndrome coronavirus
- newly diagnosed
- ejection fraction
- emergency department
- chronic kidney disease
- intensive care unit
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- clinical trial
- cross sectional
- extracorporeal membrane oxygenation
- coronary artery disease
- kidney transplantation
- acute respiratory distress syndrome